We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Increased Pressure on Healthcare Providers in the US to Adopt Telehealth

By MedImaging International staff writers
Posted on 23 Aug 2015
Print article
Young digitally-connected patients in the US are pressuring local healthcare providers to adopt telehealth solutions.

To address this, an international IT solutions and managed services provider has identified a three-stage model in the adoption of the telehealth model by healthcare providers.

According to experts at Logicalis Healthcare Solutions, the healthcare-focused arm of Logicalis US, the first stage is an ad-hoc solution; stage two includes a rationalized, departmental telehealth strategy, while stage three is a clinically integrated telehealth solution. Stage three includes advanced data exchange between healthcare providers, patients, laboratories, pharmacies and family caregivers.

Telehealth is already being used regularly in the US by 30 service lines, including radiology, neurology, and stroke care, dermatology, and behavioral health. The service lines fall into four basic telehealth categories. The first category, Synchronous telehealth, includes live, bidirectional, video-based interactions between patients and providers. The second category, Store and Forward, includes transmission of images, clinical results, education, training, and patient portals. The third category, Remote Monitoring, includes the collection of data about vital signs and health progress from chronically ill patients living at home. In the final category, Mobile Health/Wellness, care is supported by mobile devices, and promotes healthy behaviors, sends alerts and reminders, and allows remote case management such as monitoring of vital signs, advice for healthy lifestyles, and other assistance.

Ed Simcox, Healthcare practice leader, Logicalis Healthcare Solutions, said, "In the not-too-distant future, telehealth will be such an integral part of the medical experience that there will be no difference between healthcare and telehealth; telehealth will be healthcare. The tipping point, which Logicalis believes will come within the next four years, will be that point in time when more patients are using telehealth than visiting face to face with their doctors. Today's digital natives expect to interact online with service providers—including their physicians—with the same convenience they experience ride-sharing via Uber or booking a vacation room via Airbnb. To remain relevant, healthcare providers must capitalize on these expectations by providing fully integrated telehealth solutions. Those providers that haven't begun catering to the younger patient demographic using telehealth are already falling behind."

Related Links:

Logicalis Healthcare Solutions


X-ray Diagnostic System
FDX Visionary-A
New
Leg Wraps
Leg Wraps
NMUS & MSK Ultrasound
InVisus Pro
Digital X-Ray Detector Panel
Acuity G4

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.